International Journal of Drug Policy
Volume 20, Issue 4 , Pages 347-351 , July 2009

Boltushka: A homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine

  • Repsina Chintalova-Dallas

      Affiliations

    • The Fenway Institute, Fenway Community Health, Boston, MA, USA
    • ,
  • Patricia Case

      Affiliations

    • The Fenway Institute, Fenway Community Health, Boston, MA, USA
    • ,
  • Nataliya Kitsenko

      Affiliations

    • “The Way Home” Charity Fund, Odessa, Ukraine
    • ,
  • Zita Lazzarini

      Affiliations

    • Division of Medical Humanities, Health Law and Ethics, University of Connecticut Health Center, Farmington, CT, USA
    • Corresponding Author InformationCorresponding author at: Division of Medical Humanities, Health Law and Ethics, University of Connecticut Health Center, 263 Farmington Ave. MC-6325, Farmington, CT 06030-6325, United States. Tel.: +1 860 679 5494; fax: +1 860 679 5464.

Received 24 March 2008 ,Revised 3 September 2008 ,Accepted 8 September 2008.

References 

  1. Aretha D. Methamphetamine and amphetamines. Berkeley Heights, NJ: Ernslow Publishers, Inc.; 2005;
  2. Barcal K, Schumacher JE, Dumchev K, Moroz LV. A situational picture of HIV/AIDS and injection drug use in Vinnitsya, Ukraine. Harm Reduction Journal 2. 2005;16:(11 pages open access journal, at p 5)
  3. Bowler RM, Koller W, Schulz PE. Parkinsonism due to manganism in a welder: Neurological and neuropsychological sequelae. Neurotoxicology. 2006;27(3.):327–332
  4. Code of Ukraine on Administrative Offences. (1984). Law number 8073-X, clause 44, Illegal manufacture, purchase, possession, transportation of drug or psychotropic substances without the purpose of selling in small amounts, accepted on December 7, 1984.
  5. De Bie RM, Gladstone RM, Strafella AP, Ko JH, Lang AE. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Archives of Neurology. 2007;64(6):886–889
  6. Degner D, Bleich S, Riegel A, Sprung R, Poser W, Rüther E. Follow-up study after enteral manganese poisoning: Clinical, laboratory and neuroradiological findings. Nervenarzt. 2000;71(5.):416–419
  7. Egorov I. The transformation for R&D potential in Ukraine. Europe-Asia Studies. 1995;47(4):651–668
  8. Ibanez GE, Purcell DW, Stall R, Parsons JT, Gomez CA. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS. 2005;19:S49–S55
  9. International HIV/AIDS Alliance. (2006). Information on Ukraine. Retrieved May 24, 2007 at: http://www.aidsalliance.org/sw7229.asp.
  10. Kelly JA, Amirkhanian YA. The newest epidemic: A review of HIV/AIDS in Central and Eastern Europe. International Journal of STD & AIDS. 2003;14:361–371
  11. Kuleshova E. Personal communication with psychologist at the Charity Fund. Odessa, Ukraine: The Way Home; 2006;
  12. Matic S, Lazarus JV, Donoghoe MC. HIV/AIDS in Europe: Moving from death sentence to chronic disease management. WHO Regional Office for Europe; 2006;
  13. Meral H, Kutukcu Y, Atmaca B, Ozer F, Hamamcioglu K. Parkinsonism caused by chronic usage of intravenous potassium permanganate. Neurologist. 2007;13:92–94
  14. Ministry of Health. (2003). Order of Ministry of Health of Ukraine from May 14, # 210; Registered in Ministry of Justice on November 5, 2003 # 1012/8333.
  15. Ministry of Health. (2005). Order of the Ministry of Heath of the Ukraine date July 19, #360 (z0782-05); Registered at the Ministry of Justice of Ukraine on June 20, 2005 under the number 783/11063.
  16. Novoa RA, Ompad DC, Wu Y, Vlahov D, Galea S. Ecstasy use and its association with sexual behaviors among drug users in New York City. Journal of Community Health. 2005;30:331–343
  17. Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: The social and economic context of epidemics. Addiction. 1999;94(9):1323–1336
  18. Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S. Manganic encephalopathy due to “ephedrone” abuse. Movement Disorders. 2007;22(9):1337–1343
  19. Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkājis A, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. New England Journal of Medicine. 2008;358(10):1009–1017
  20. United Nations Office on Drugs and Crime (UNODC). (2004). Drugs and crime trends in Europe and beyond. Vienna: UNODC. Retrieved 24 May 2007 at: http://www.unodc.org/pdf/factsheets/unodc_factsheet_eu_29-04-2004.pdf.
  21. World Bank and International HIV/AIDS Alliance. (2006). Socioeconomic impact of HIV/AIDS in Ukraine. Washington, DC. Retrieved May 24, 2007 at: http://siteresources.worldbank.org/INTUKRAINE/Resources/328335-1147812406770/ukr_aids_eng.pdf.
  22. World Health Organization (WHO). (2006). Disease control priorities related to mental, neurological, developmental and substance abuse disorders. Geneva: Disease Control Priorities Project, Department of Mental Health and Substance Abuse, WHO. Retrieved 24 May 2007 at: http://www.who.int/substance_abuse/publications/en/Neuroscience.pdf.

PII: S0955-3959(08)00196-5

doi: 10.1016/j.drugpo.2008.09.003

International Journal of Drug Policy
Volume 20, Issue 4 , Pages 347-351 , July 2009

Article Tools